A Phase 2, 26 Week, Multicentre, Randomized Double Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy and Safety of Tolterodine, Pregabalin and a Tolterodine-Pregabalin Combination for Idiopathic Overactive Bladder.
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2017
At a glance
- Drugs Pregabalin; Tolterodine
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Pfizer
- 19 Sep 2008 New trial record.